Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

King Saud University Scientist Part Of Cancer Breakthrough
King Saud University professor, Dr. Adel Almogren, along with a diverse team of academic researchers from the United States, Canada, and Taiwan, has discovered a new process that could lead to a vaccine to block cancer cell adhesion and growth.
generic viagra online
MGH Study Identifies First Molecular Steps To Childhood Leukemia
A Massachusetts General Hospital (MGH)-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL)- the most common cancer in children- initiates the disease process. In the July issue of Cell Stem Cell, they describe how expression of this mutation in hematopoietic stem cells (HSCs), which usually occurs before birth, leads to the development of leukemia many years later.
News of the day
A Real-Life Example Of Humans' Dual Vision System
It"s rare when real-world events perfectly mirror experiments that scientists are conducting.
Nutrition

Aberrant ERG Expression Cooperates With Loss Of PTEN To Promote Cancer Progression In The Prostate

UroToday.com - Two papers in the May 5, 2009 edition of Nature Genetics link ERG chromosomal gene translocations with loss of PTEN in the early stages of prostate cancer (CaP) progression. Both are reviewed in Urotoday. In this report, Dr. Brett Carver and colleagues studied TMPRSS2-ERG genetic rearrangement, which are reported in up to 50% of primary prostate cancer tumors. The ETS overexpression is also linked to the invasive and metastatic phenotype. ERG rearrangements are not commonly found in high-grade PIN (HGPIN), even though it is present in surrounding CaP areas from the same primary tumor. They validated this by microarray of 40 CaP tumors. PTEN loss or alteration occurs in 30-70% of CaP tumors, and the investigators evaluated whether loss of PTEN and ERG genetic rearrangements is a concomitant event in CaP. Among 40 CaP specimens, PTEN protein expression was decreased or absent in 68% of samples and ERG rearrangements by FISH analysis were present in 38%. Fourteen of 15 ERG-positive samples had altered PTEN expression. They also tested their hypothesis in mice. In Pten knockout mice with concomitant p53 loss, mRNA levels in tumors showed markedly increased levels of ERG. To further understand whether aberrant prostatic expression of ERG would interact with PTEN loss to promote CaP development and progression in mice, they generated mice expressing ERG under the control of the probasin promoter (PB-ERG). The phenotype was a highly invasive CaP with reduced cancer latency. The overexpression of ERG did not seem to directly affect PTEN levels, but it somehow interacted through a complementary pathway. In vitro delineation of this found that while proliferation was not altered, tumor cell migration was increased. Microarray identified the chemokine receptor CXCR4 as transcriptionally upregulated. CXCR4 was found to have 2 ETS promoter binding regions and knockdown of CXCR4 inhibited cell migration. These data link two frequent and critical events in CaP to promote tumor development and progression. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP Nat Genet. 2009 May;41(5):619-24. doi: 10.1038/ng.370 Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009